Market Cap
$110.4B
MDT
Medtronic plc
$86.86 ▲ +0.49%
Prev close $86.44Market cap$110.4B
ConsensusBuy
12-mo target$104.83 (+20.7%)
▲ Bullish
Analyst conviction 7/10
High Impact Filing (7/10)Congressional Activity (2) Healthcare & Medical Devices
Snapshot
The big-picture read on MDT right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Buy (68%)
Insider Activity
$0.00 buy / $733.8K sell
Insider Net $
-$733.8K
Social Sentiment
71° Bullish
SEC Reports
19
Press Releases
2
Congressional
4 trades
Price chart 30d -5.8%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 other
Medtronic Receives Category I CPT® Code Approvals for Altaviva™ and Symplicity Spyral™ Systems
Coding approvals reflect growing clinical evidence and physician adoption of Medtronic solutions add
Sep 30, 2026 Event
Sep 16, 2026 Press Medtronic Sofamor Danek USA, Inc. v. River City Spine, LLC et al
Court ruling (tnwd) — Docket: 2:25-cv-02474
Medtronic announced FDA clearance for the LigaSure RAS Maryland jaw device on its Hugo RAS system, expanding the instrum
Impact 4/10
Medtronic plc filed a Rule 425 prospectus communication in connection with its pending business combination. The filing
425 — Impact 4/10
Sep 16, 2026 Insider
KIIL HARRY SKIP sold 1,483 shares
EVP & President Cardiovascular @ $93.65 ($138.9K)
Sep 15, 2026 Insider
Sep 1, 2026 Press Blomquist Denise L. gifted 600 shares
Chief Accounting Officer
Medtronic announced a ~$700M strategic investment in Cornerstone Robotics and a distribution agreement for the Sentire s
Impact 5/10
Aug 24, 2026 Congress
Kevin Hern sell
$15,001 - $50,000 — House
Analyst ratings buy % +33.3%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
68% rate it Buy or better · 34 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 30, 2026 | TD Cowen | REITERATE | Buy | 56% |
| Sep 3, 2026 | UBS | MAINTAIN | Buy | 55% |
| Sep 2, 2026 | Truist Securities | REITERATE | Hold | 55% |
| Sep 2, 2026 | Wells Fargo | MAINTAIN | Overweight | 54% |
| Sep 2, 2026 | RBC Capital | REITERATE | Outperform | 55% |
| Sep 2, 2026 | B of A Securities | MAINTAIN | Buy | 54% |
| Sep 2, 2026 | Stifel | MAINTAIN | Hold | 54% |
| Sep 2, 2026 | Baird | MAINTAIN | Neutral | 54% |
| Sep 1, 2026 | BTIG | MAINTAIN | Buy | 53% |
| Sep 1, 2026 | Needham | REITERATE | Buy | 50% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 10 | 13 | 11 | 0 | 0 | 68% | |
| Aug 1, 2026 | 10 | 12 | 12 | 0 | 0 | 65% | |
| Jul 1, 2026 | 10 | 12 | 14 | 1 | 0 | 59% | |
| Jun 1, 2026 | 8 | 13 | 15 | 1 | 0 | 57% | |
| May 1, 2026 | 8 | 15 | 13 | 1 | 0 | 62% | |
| Apr 1, 2026 | 8 | 15 | 13 | 1 | 0 | 62% | |
| Mar 1, 2026 | 8 | 16 | 13 | 1 | 0 | 63% | |
| Feb 1, 2026 | 7 | 13 | 14 | 1 | 0 | 57% |
Price targets
Where 24 covering analysts think MDT trades over the next 12 months.
$104.83 +20.7% upside Strong Buy
Current$86.87 Low$85.00 Median$106.00 High$121.00 24 analysts
$85.00$121.00
Analyst rating Buy· 1.8/5 as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
71°
Bullish
BearishNeutralBullish
Recent posts
Lot of activity surrounding Metronic (MDT) shares lately
▲ 1 · 💬 1· ⚡ 0.5
Tracked 15 pre-market gaps from the open to midday. Every up-gap held. 6 of 10 down-gaps faded.
▲ 1 · 💬 5· ⚡ 0.5
Medtech, Medtronic are gaining
▲ 1 · 💬 0· ⚡ 0.5
Medtronic’s turnaround is getting harder to ignore.
▲ 1 · 💬 0· ⚡ 0.5
9 oversold alerts in S&P today. AMD up 82% vs market in 20 days
▲ 1 · 💬 0· ⚡ 0.4
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
19 SEC filing reports analyzed · 7 bullish, 0 bearish, 1 mixed, 11 neutral · avg impact 3.9/10.Plus 2 press releases.
BULLISHANALYST-UPGRADE2/10
BTIG upgrades MDT to Buy — PT $90 (+15.5%)
Jun 4, 2026
BULLISHANALYST-UPGRADE4/10
UBS upgrades MDT to Buy — PT $100 (+18.7%)
Jul 28, 2026
NEUTRAL4254/10
Medtronic plc filed a Rule 425 prospectus communication in connection with its pending business comb
Sep 16, 2026
NEUTRAL4253/10
Medtronic filed two additional 425 communications on September 14, 2026, providing internal talking
Sep 14, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
other
Medtronic Receives Category I CPT® Code Approvals for Altaviva™ and Symplicity Spyral™ Systems
Coding approvals reflect growing clinical evidence and physician adoption of Medtronic solutions addressing urge urinary incontinence and hypertension
Sep 30, 2026
short_volume
Short Volume: MDT — 57.6% short (3.5M / 6.1M)
Short: 3,539,135 | Exempt: 2,814 | TRF Vol: 6,142,594 | Short Ratio: 57.6% | Off-exchange volume (dark pool + OTC)
Sep 30, 2026
Enforcement
Medtronic Sofamor Danek USA, Inc. v. River City Spine, LLC et al
Court ruling (tnwd) — Docket: 2:25-cv-02474
Sep 29, 2026
Enforcement
Radtkin et al. v. Medtronic, Inc. et al.
Court ruling (ohnd) — Docket: 3:24-cv-00290
Sep 28, 2026
short_volume
Short Volume: MDT — 68.5% short (5.9M / 8.6M)
Short: 5,861,908 | Exempt: 12,830 | TRF Vol: 8,563,169 | Short Ratio: 68.5% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $1.33 | $1.32–$1.34 | -2.1% | -1.2% | 3↑ 13↓ | $9.5B | 23 |
| Next Q | $1.42 | $1.38–$1.48 | 4.7% | -0.6% | 2↑ 11↓ | $9.5B | 23 |
| Current FY | $5.97 | $5.94–$6.01 | 8.0% | +0.4% | 19↑ 2↓ | $39.1B | 27 |
| Next FY | $6.41 | $6.24–$6.63 | 7.3% | +0.1% | 9↑ 13↓ | $40.4B | 28 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $1.331 | — |
| 7d ago | $1.331 | -0.000 |
| 30d ago | $1.347 | -0.016 |
| 60d ago | $1.347 | -0.016 |
| 90d ago | $1.347 | -0.016 |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
8 insiders, 50 transactions. Net -$733.8K — $0.00 bought, $733.8K sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | SELL | 1,483 | $93.65 | $138.9K |
| Sep 15, 2026 | Blomquist Denise L. | Chief Accounting Officer | GIFT | 600 | — | — |
| Aug 20, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | TAX W/H | 1,084 | $92.30 | $100.1K |
| Aug 3, 2026 | Blomquist Denise L. | Chief Accounting Officer | AWARD | 2,337 | — | — |
| Aug 3, 2026 | Blomquist Denise L. | Chief Accounting Officer | AWARD | 2,337 | — | — |
| Aug 3, 2026 | Blomquist Denise L. | Chief Accounting Officer | AWARD | 1,366 | — | — |
| Aug 3, 2026 | Walter Matthew R. | SVP, Chief HR Officer | AWARD | 5,769 | — | — |
| Aug 3, 2026 | Quinn Michelle | EVP, GC and Secretary | AWARD | 45,070 | — | — |
| Aug 3, 2026 | Walter Matthew R. | SVP, Chief HR Officer | AWARD | 14,421 | — | — |
| Aug 3, 2026 | Walter Matthew R. | SVP, Chief HR Officer | AWARD | 40,973 | — | — |
Congressional trades
MDT trades disclosed by members of Congress, with disclosure delay.
3 members · 0 buys / 4 sells
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | Kevin Hern | R | HOUSE | SELL | $15,001 - $50,000 | Medtronic PLC | Sep 2, 2026(10d) |
| Jul 30, 2026 | Rich McCormick | R | HOUSE | SELL | $1,001 - $15,000 | Medtronic PLC | Aug 17, 2026(19d) |
| Mar 20, 2026 | Kevin Hern | R | HOUSE | SELL | $15,001 - $50,000 | Medtronic PLC | Apr 6, 2026(18d) |
| May 7, 2025 | Julie Johnson | D | HOUSE | SELL | $1,001 - $15,000 | Medtronic PLC | Aug 6, 2026(457d) |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for MDT.
Shares short
17,229,743
Settlement Sep 15, 2026
Change vs prior
+42.0%
Semi-monthly cycle
Days to cover
2.0
At avg daily volume
Of shares outstanding
≈1.4%
Estimate — not % of float
All MDT filing & press-release reports (21)
- UBS upgrades MDT to Buy — PT $100 (+18.7%)Jul 28, 2026
- BTIG upgrades MDT to Buy — PT $90 (+15.5%)Jun 4, 2026
- PRESS-RELEASE reportSep 16, 2026
- 425 reportSep 16, 2026
- 425 reportSep 14, 2026
- 425 reportSep 14, 2026
- 425 reportSep 14, 2026
- COURT-RULING reportSep 1, 2026
- PRESS-RELEASE reportSep 1, 2026
- PRESS-RELEASE reportSep 1, 2026
- 8-K reportSep 1, 2026
- PRESS-RELEASE reportAug 20, 2026
- COURT-RULING reportAug 14, 2026
- COURT-RULING reportAug 14, 2026
- COURT-RULING reportJul 31, 2026
- PRESS-RELEASE reportJul 20, 2026
- COURT-RULING reportJul 17, 2026
- COURT-RULING reportJul 15, 2026
- 8-K reportJun 3, 2026
- COURT-RULING reportMay 19, 2026
- COURT-RULING reportApr 6, 2026